Roche Presents Results from the Phase III PEMPHIX Study for Patients with Pemphigus Vulgaris TrialSite News, 17 Oct 2019 Roche announced that its Phase III PEMPHIX study reveals the superiority of MabThera/Rituxan (rituximab) over mycophenolate…